Summary:

- Researchers have developed a single-dose drug that effectively eliminated breast tumors in mice without causing any adverse side effects.
- The drug, called DT2216, targets a protein called BCL-XL that is essential for the survival of cancer cells, leading to their rapid and complete destruction.
- This breakthrough could potentially lead to a new, more effective, and less toxic treatment option for breast cancer patients, offering hope for a better outcome and improved quality of life.